• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP ANTIMICROBIAL RESISTANCE SCAN: Resistant Shigella; AMR and poverty

Shiloh

Editor, Senior Moderator
Source: http://www.cidrap.umn.edu/news-perspective/2016/10/antimicrobial-resistance-scan-oct-05-2016

Antimicrobial Resistance Scan for Oct 05, 2016
Resistant Shigella; AMR and poverty

Filed Under:
Antimicrobial Stewardship
[h=3]UK researchers note worrisome antibiotic-resistant Shigella cluster[/h] A UK study this week notes highly resistant Shigella sonnei isolates from men who have sex with men (MSM) who had engaged in high-risk activities, while Canadian scientists report a different antibiotic-resistant Shigella strain in a man with HIV, according to separate reports in Emerging Infectious Diseases.
In the first study, researchers from Public Health England report identifying a cluster of S sonnei in November 2015 that showed high levels of resistance to amoxicillin, ceftriaxone, tetracycline, sulphonamides, trimethoprim, and azithromycin and produced extended-spectrum beta-lactamase (ESBL). Those findings led the agency to sequence about 70% of S sonnei isolates obtained from hospital labs since August 2015.
Their investigation revealed nine patients whose fecal specimens tested positive for resistant S sonnei. Their gastrointestinal symptoms began from September to late December 2015. All seven patients who answered detailed questions about sexual history reported having male partners. Six reported sexual activities considered to be high risk for Shigella transmission, such as oral-anal contact and attendance at sex parties.
Isolates from all nine men produced ESBL and exhibited macrolide resistance. Whole-genome sequencing showed a close relationship among the isolates, which harbored a previously identified plasmid that has since acquired a mobile element, making it more easily transferred to another pathogen, the authors reported. No epidemiologic links were found among the patients, and no point sources were identified, making foodborne acquisition less likely.
In Canada, the researchers reported S flexneri in a 53-year-old HIV-positive MSM that was resistant to ampicillin, trimethoprim/sulfamethoxazole, nalidixic acid, ciprofloxacin, tetracycline, and chloramphenicol. It was susceptible to ceftriaxone, cefixime, ertapenem, and gentamicin and was also isolated last year.
Oct 3 Emerg Infect Dis UK report
Oct 3 Emerg Infect Dis Canadian case report

[h=3]Study links nations' poverty to higher antimicrobial resistance levels[/h] Researchers from India reported yesterday that countries with lower per-capita income have higher levels of antimicrobial resistance (AMR).
Writing in the International Journal of Infectious Diseases, a trio of scientists compared 2013-2014 gross national income per capita (GNIPC) with the prevalence of three common resistant bacteria: third-generation cephalosporin (3GC)-resistant Escherichia coli, methicillin-resistant Staphylococcus aureus (MRSA), and 3GC-resistant Klebsiella. Their analysis included 43 countries.
The researchers found that, for each log increase in GNIPC, levels of 3GC-resistant E coli, 3GC-resistant Klebsiella, and MRSA dropped 11.3%, 18.2%, and 12.3%, respectively. The association was stronger, however, for E coli and Klebsiella than for MRSA.
The authors concluded, "Our results underscore the urgent necessity of new policies aiming at reducing AMR in resource-poor settings."
Oct 4 Int J Infect Dis study
 
Back
Top Bottom